Letter E | page 1 | drug substances index

Econazole

Indicated for: fungal skin infections

G01AF05 Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Imidazole derivatives

Eculizumab

Indicated for: complement-mediated disorders

L04AJ01 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors

Edetate of sodium and calcium

Indicated for: lead poisoning

V03AB03 Various | All other therapeutic products | All other therapeutic products | Antidotes

Edoxaban

Indicated for: prevention and treatment of thromboembolism

B01AF03 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Direct factor xa inhibitors

Efalizumab

Indicated for: psoriasis

L04AA21 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Efavirenz

Indicated for: HIV-1 infection

J05AG03 Antiinfectives for systemic use | Direct acting antivirals | Non-nucleoside reverse transcriptase inhibitors

Efavirenz + emtricitabine + tenofovir

Indicated for: HIV-1 infection

J05AR06 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Efavirenz + emtricitabine + tenofovir disoproxil

Indicated for: HIV-1 infection

J05AR06 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Efgartigimod alfa

Indicated for: myasthenia gravis

L04AA58 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Eflornithine

Indicated for: facial hirsutism; African trypanosomiasis

D11AX Dermatologicals | Other dermatological preparations | Other dermatological preparations | Other dermatologicals

Efmoroctocog alfa

Indicated for: bleeding; coagulation disorders

B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors

Eftrenonacog alfa

Indicated for: bleeding; coagulation disorders

B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors

Elacestrant

Indicated for: breast cancer

L02BA04 Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens

Elafibranor

Indicated for: primary biliary cholangitis

A05AX06 Alimentary tract and metabolism | Bile therapy | Other drugs for bile therapy

Elbasvir + grazoprevir

Indicated for: chronic hepatitis C

J05AP54 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections

Electrolytes

Indicated for: electrolyte imbalance

B05BB01 Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance

Eletriptan

Indicated for: migraine

N02CC06 Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists

Eliglustat

Indicated for: Gaucher disease

A16AX10 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Elosulfase alfa

Indicated for: lysosomal enzyme deficiency

A16AB12 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Elranatamab

Indicated for: hematologic malignancies

L01FX32 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates

Eltrombopag

Indicated for: thrombocytopenia

B02BX05 Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics

Elvitegravir + cobicistat + emtricitabine + tenofovir

Indicated for: HIV-1 infection

J05AR18 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Emedastine

Indicated for: allergic conjunctivitis

S01GX06 Sensory organs | Decongestants and antiallergics | Other antiallergics

Emicizumab

Indicated for: hemophilia

B02BX06 Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics

Empagliflozin

Indicated for: type 2 diabetes mellitus; heart failure; chronic kidney disease

A10BK03 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sodium-glucose co-transporter 2 (SGLT2) inhibitors

Empagliflozin + metformin

Indicated for: type 2 diabetes mellitus

A10BD20 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs

Emtricitabine

Indicated for: HIV-1 infection

J05AF09 Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Emtricitabine + rilpivirine + tenofovir alafenamide

Indicated for: HIV-1 infection

J05AR19 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Emtricitabine + tenofovir

Indicated for: HIV-1 infection

J05AR03 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Emtricitabine + tenofovir alafenamide

Indicated for: HIV-1 infection

J05AR17 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Search for medicines for human use

Index of medicine substances

Econazole

Eculizumab

Edetate of sodium and calcium

Edoxaban

Efalizumab

Efavirenz

Efavirenz + emtricitabine + tenofovir

Efavirenz + emtricitabine + tenofovir disoproxil

Efgartigimod alfa

Eflornithine

Efmoroctocog alfa

Eftrenonacog alfa

Elacestrant

Elafibranor

Elbasvir + grazoprevir

Electrolytes

Eletriptan

Eliglustat

Elosulfase alfa

Elranatamab

Eltrombopag

Elvitegravir + cobicistat + emtricitabine + tenofovir

Emedastine

Emicizumab

Empagliflozin

Empagliflozin + metformin

Emtricitabine

Emtricitabine + rilpivirine + tenofovir alafenamide

Emtricitabine + tenofovir

Emtricitabine + tenofovir alafenamide